🇺🇸 FDA
Patent

US 12129258

Diaryl macrocyclic compound and pharmaceutical composition, and use thereof

granted A61PA61P35/00

Quick answer

US patent 12129258 (Diaryl macrocyclic compound and pharmaceutical composition, and use thereof) held by PrimeGene (Beijing) Co., Ltd. expires Mon Oct 24 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
PrimeGene (Beijing) Co., Ltd.
Grant date
Tue Oct 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 24 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61P, A61P35/00